Literature DB >> 19424209

The sepsis seesaw: tilting toward immunosuppression.

Richard S Hotchkiss1, Craig M Coopersmith, Jonathan E McDunn, Thomas A Ferguson.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19424209      PMCID： PMC3786779          DOI： 10.1038/nm0509-496

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

Review 1.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

Review 2.  Novel therapies for sepsis: a review.

Authors:  Katherine J Deans; Michael Haley; Charles Natanson; Peter Q Eichacker; Peter C Minneci
Journal:  J Trauma       Date:  2005-04

3.  Enhanced regulatory T cell activity is an element of the host response to injury.

Authors:  Niamh Ni Choileain; Malcolm MacConmara; Yan Zang; Thomas J Murphy; John A Mannick; James A Lederer
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

4.  CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance.

Authors:  T S Griffith; X Yu; J M Herndon; D R Green; T A Ferguson
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

5.  Agonistic monoclonal antibody against CD40 receptor decreases lymphocyte apoptosis and improves survival in sepsis.

Authors:  Steven J Schwulst; Mitchell H Grayson; Peter J DiPasco; Christopher G Davis; Tejal S Brahmbhatt; Thomas A Ferguson; Richard S Hotchkiss
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

6.  Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.

Authors:  Charles-Edouard Luyt; Alain Combes; Claire Deback; Marie-Hélène Aubriot-Lorton; Ania Nieszkowska; Jean-Louis Trouillet; Frédérique Capron; Henri Agut; Claude Gibert; Jean Chastre
Journal:  Am J Respir Crit Care Med       Date:  2007-01-18       Impact factor: 21.405

7.  Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.

Authors:  Marcin F Osuchowski; Kathy Welch; Javed Siddiqui; Daniel G Remick
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 8.  Twelve immunotherapy drugs that could cure cancers.

Authors:  Martin A Cheever
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

9.  PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis.

Authors:  Xin Huang; Fabienne Venet; Yvonne L Wang; Alain Lepape; Zhenglong Yuan; Yaping Chen; Ryan Swan; Hakim Kherouf; Guillaume Monneret; Chun-Shiang Chung; Alfred Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

10.  MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.

Authors:  Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307
View more
  245 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

2.  Cecal ligation and puncture followed by methicillin-resistant Staphylococcus aureus pneumonia increases mortality in mice and blunts production of local and systemic cytokines.

Authors:  Enjae Jung; Erin E Perrone; Zhe Liang; Elise R Breed; Jessica A Dominguez; Andrew T Clark; Amy C Fox; W Michael Dunne; Eileen M Burd; Alton B Farris; Richard S Hotchkiss; Craig M Coopersmith
Journal:  Shock       Date:  2012-01       Impact factor: 3.454

Review 3.  Macrophage polarization and plasticity in health and disease.

Authors:  Subhra K Biswas; Manesh Chittezhath; Irina N Shalova; Jyue-Yuan Lim
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 4.  A historical perspective on sepsis.

Authors:  Peter A Ward; Markus Bosmann
Journal:  Am J Pathol       Date:  2012-05-26       Impact factor: 4.307

5.  Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation.

Authors:  Jonathan Campbell; Joanne Trgovcich; Michelle Kincaid; Peter D Zimmerman; Paul Klenerman; Stuart Sims; Charles H Cook
Journal:  J Leukoc Biol       Date:  2012-06-22       Impact factor: 4.962

6.  Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis.

Authors:  Pavan Brahmamdam; Shigeaki Inoue; Jacqueline Unsinger; Katherine C Chang; Jonathan E McDunn; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2010-05-18       Impact factor: 4.962

Review 7.  The inflammatory response in sepsis.

Authors:  Markus Bosmann; Peter A Ward
Journal:  Trends Immunol       Date:  2012-10-02       Impact factor: 16.687

8.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Genomic responses in mouse models greatly mimic human inflammatory diseases.

Authors:  Keizo Takao; Tsuyoshi Miyakawa
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

10.  Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis.

Authors:  Georg F Weber; Benjamin G Chousterman; Shun He; Ashley M Fenn; Manfred Nairz; Atsushi Anzai; Thorsten Brenner; Florian Uhle; Yoshiko Iwamoto; Clinton S Robbins; Lorette Noiret; Sarah L Maier; Tina Zönnchen; Nuh N Rahbari; Sebastian Schölch; Anne Klotzsche-von Ameln; Triantafyllos Chavakis; Jürgen Weitz; Stefan Hofer; Markus A Weigand; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.